Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Singapore Says Biomedical Investment Totals $860 Million in 2009

publication date: Apr 16, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Singapore reported that biomedical companies invested $860 million in fixed assets during 2009 with multinational companies building either regional headquarters (Medtronic, Quintiles, Takeda), first-in-Asia and global manufacturing facilities (GlaxoSmithKline, Illumina, Lonza, Medtronic, ResMed, Roche) or Asian R&D bases (Abbott, 3M, Merck, Roche, Inviragen, Forma). More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...